ATE482698T1 - Vermeidung von vorhofflimmern (af) mit der verwendung von statin - Google Patents

Vermeidung von vorhofflimmern (af) mit der verwendung von statin

Info

Publication number
ATE482698T1
ATE482698T1 AT04737850T AT04737850T ATE482698T1 AT E482698 T1 ATE482698 T1 AT E482698T1 AT 04737850 T AT04737850 T AT 04737850T AT 04737850 T AT04737850 T AT 04737850T AT E482698 T1 ATE482698 T1 AT E482698T1
Authority
AT
Austria
Prior art keywords
atrial fibrillation
statin
promotion
preventing atrial
attenuate
Prior art date
Application number
AT04737850T
Other languages
English (en)
Inventor
Stanley Nattel
Original Assignee
Inst Cardiologie De Montreal M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Cardiologie De Montreal M filed Critical Inst Cardiologie De Montreal M
Application granted granted Critical
Publication of ATE482698T1 publication Critical patent/ATE482698T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catching Or Destruction (AREA)
AT04737850T 2003-06-18 2004-06-18 Vermeidung von vorhofflimmern (af) mit der verwendung von statin ATE482698T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47914703P 2003-06-18 2003-06-18
PCT/CA2004/000911 WO2004110427A1 (en) 2003-06-18 2004-06-18 Preventing atrial fibrillation (af) with the use of statin drugs

Publications (1)

Publication Number Publication Date
ATE482698T1 true ATE482698T1 (de) 2010-10-15

Family

ID=33551865

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04737850T ATE482698T1 (de) 2003-06-18 2004-06-18 Vermeidung von vorhofflimmern (af) mit der verwendung von statin

Country Status (6)

Country Link
US (1) US20060178424A1 (de)
EP (1) EP1638548B1 (de)
AT (1) ATE482698T1 (de)
CA (1) CA2529367C (de)
DE (1) DE602004029362D1 (de)
WO (1) WO2004110427A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9072816B2 (en) * 2006-01-18 2015-07-07 Cormatrix Cardiovascular, Inc. Composition for modulating inflammation of cardiovascular tissue
US8962324B2 (en) 2006-01-18 2015-02-24 Cormatrix Cardiovascular, Inc Method and system for treatment of biological tissue
US9532943B2 (en) 2010-12-20 2017-01-03 Cormatrix Cardiovascular, Inc. Drug eluting patch for the treatment of localized tissue disease or defect
PL3000472T3 (pl) * 2009-02-18 2017-09-29 Cormatrix Cardiovascular, Inc. Kompozycje do zapobiegania migotaniu przedsionków i komór
SG191737A1 (en) * 2010-12-20 2013-08-30 Cormatrix Cardiovascular Inc A drug eluting patch for the treatment of localized tissue disease or defect

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS591415A (ja) * 1982-06-28 1984-01-06 Mochida Pharmaceut Co Ltd 循環系疾患治療剤
FR2751540B1 (fr) * 1996-07-26 1998-10-16 Sanofi Sa Composition pharmaceutique antithrombotique
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
EP1216037A2 (de) * 1999-09-21 2002-06-26 Emory University Verfahren und zusammensetzungen zur behandlung von bluttplätchen-zusammenhängenden krankheiten, mit mpl hemmenden agenten

Also Published As

Publication number Publication date
CA2529367C (en) 2012-09-11
EP1638548B1 (de) 2010-09-29
EP1638548A1 (de) 2006-03-29
CA2529367A1 (en) 2004-12-23
DE602004029362D1 (de) 2010-11-11
WO2004110427A1 (en) 2004-12-23
US20060178424A1 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
DE60313472D1 (de) Pyrrolidindion-substituierte piperidin-phthalazone als pde4-inhibitoren
EA200000768A1 (ru) ЗАМЕЩЕННЫЕ ОКСОАЗАГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ ФАКТОРА Ха
DE60319364D1 (de) Substituierte pyrroline als kinase inhibitoren
EA200600594A1 (ru) Новые гетероциклические соединения - ингибиторы hsp90 и способы их получения
ATE479687T1 (de) Kinaseinhibitoren
EA199900837A1 (ru) Способ применения ингибиторов циклооксигеназы-2 для предупреждения сердечно-сосудистых расстройств
DE69912581D1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
ATE217865T1 (de) Verbindungen zur hemmung von phosphodiesrerase iv
ATE501126T1 (de) Verfahren zur herstellung von rosuvastatin
ATE409035T1 (de) Substituierte pyrroline als kinase inhibitoren
EA200300836A1 (ru) Производные фталазинон-пиперидина в качестве ингибиторов pde4
DE60305061D1 (de) 2-pyridonderivate als inhibitoren von neutrophiler elastase
BR0211274A (pt) Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase
ATE387429T1 (de) Arly- und heteroaryl-substituierte tetrahydroisoquinoline und ihre verwendung als hemmer der wiederaufnahme von norepinephrin, dopamin und serotonin
DE602005013923D1 (de) Derivate von piperidinylalkylcarbamaten, herstellungsverfahren davon und verwendung derselben als faah-enzym-inhibitoren
BRPI0509926A (pt) imidazóis
WO2005014539A3 (en) Pyrrole-based hmg-coa reductase inhibitors
NO923089D0 (no) Tetrahydroindazol, tetrahydrocyklopentapyrazol og heksahydrocykloheptapyrazol forbindelser og deres anvendelse som hmg-coa reduktase-hemmere
ATE361296T1 (de) Pyrazolidin-1,2-dicarbonsäure-1-((phenyl)-amid) 2-((phenyl)-amid) derivate als koagulationsfaktor xa inhibitoren zur behandlung von thrombosen
ATE496025T1 (de) Magnesiumsalze von hmg-coa-reduktase-hemmern
DE602004012448D1 (de) Morpholinylhaltige benzimidazole als inhibitoren der replikation von respiratory syncytial virus
ATE482698T1 (de) Vermeidung von vorhofflimmern (af) mit der verwendung von statin
ATE444299T1 (de) Neue boronatester
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
BRPI0417138A (pt) n-alquil-pirroles como inibidores de hmg-coa-redutase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties